Back to Search

EDWARD ALAN COPELAN MD

MD

Hematology (Internal Medicine) Physician

NPI: 1962417451Individual

Specialties, Licenses & Credentials

Internal Medicine Physician

Internal Medicine

Code: 207R00000X

2012-02388(NC)
Hematology & Oncology Physician

Internal Medicine — Hematology & Oncology

Code: 207RH0003X

2012-02388(NC)
Medical Oncology Physician

Internal Medicine — Medical Oncology

Code: 207RX0202X

2012-02388(NC)
Hematology (Internal Medicine) PhysicianPrimary

Internal Medicine — Hematology

Code: 207RH0000X

2012-02388(NC)

Research & Publications (20)

Late mortality and relapse following BuCy2 and HLA-identical sibling marrow transplantation for chronic myelogenous leukemia.
PMID 19539217·Biol Blood Marrow Transplant·2009
3-trial
A randomized trial of etoposide and G-CSF with or without rituximab for PBSC mobilization in B-cell non-Hodgkin's lymphoma.
PMID 18794865·Bone Marrow Transplant·2009
2-rct
A scheme for defining cause of death and its application in the T cell depletion trial.
PMID 18022577·Biol Blood Marrow Transplant·2007
4-observational
Hematopoietic stem-cell transplantation.
PMID 16641398·N Engl J Med·2006
6-review
Therapy-related myelodysplasia and leukemia occur infrequently following VP-16 priming and autotransplantation without total body irradiation.
PMID 15156164·Bone Marrow Transplant·2004
3-trial
Busulfan levels are influenced by prior treatment and are associated with hepatic veno-occlusive disease and early mortality but not with delayed complications following marrow transplantation.
PMID 11551021·Bone Marrow Transplant·2001
8-other
Autotransplantation following busulfan, etoposide and cyclophosphamide in patients with non-Hodgkin's lymphoma.
PMID 10871728·Bone Marrow Transplant·2000
3-trial
Analysis of prognostic factors for allogeneic marrow transplantation following busulfan and cyclophosphamide in myelodysplastic syndrome and after leukemic transformation.
PMID 10871724·Bone Marrow Transplant·2000
3-trial
The influence of early transplantation, age, GVHD prevention regimen, and other factors on outcome of allogeneic transplantation for CML following BuCy.
PMID 11108300·Bone Marrow Transplant·2000
8-other
Are backup BM harvests worthwhile in unrelated donor allogeneic transplants?
PMID 19421170·Bone Marrow Transplant·2010
8-other
Elevated pretransplant serum ferritin is associated with inferior survival following nonmyeloablative allogeneic transplantation.
PMID 19377514·Bone Marrow Transplant·2009
8-other
A prognostic scoring system for adult patients less than 60 years of age with acute lymphoblastic leukemia in first relapse.
PMID 19557633·Leuk Lymphoma·2009
8-other
Treatment of acute myeloid leukemia with hematopoietic stem cell transplantation.
PMID 19450182·Future Oncol·2009
6-review
Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients.
PMID 18827183·Blood·2009
8-other
Elevated pretransplant ferritin is associated with a lower incidence of chronic graft-versus-host disease and inferior survival after myeloablative allogeneic haematopoietic stem cell transplantation.
PMID 19508292·Br J Haematol·2009
3-trial
Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
PMID 18195688·Bone Marrow Transplant·2008
8-other
Elevated ferritin is associated with relapse after autologous hematopoietic stem cell transplantation for lymphoma.
PMID 18940678·Biol Blood Marrow Transplant·2008
8-other
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
PMID 18664621·Blood·2008
8-other
Time to post-remission therapy is an independent prognostic factor in adults with acute lymphoblastic leukemia.
PMID 18766970·Leuk Lymphoma·2008
8-other
HLA-identical sibling allogeneic transplants versus chemotherapy in acute myelogenous leukemia with t(8;21) in first complete remission: collaborative study between the German AML Intergroup and CIBMTR.
PMID 18215779·Biol Blood Marrow Transplant·2008
4-observational

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Via CAROLINAS HEALTHCARE SYSTEM · 4 locations total

Address
1021 MOREHEAD MEDICAL DR, STE A
CHARLOTTE, NC 28204
Practice locations map

Locations (4)

CAROLINAS HEALTHCARE SYSTEM

1021 MOREHEAD MEDICAL DR, CHARLOTTE, NC
(980) 442-2000

THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY

4525 CAMERON VALLEY PKWY, CHARLOTTE, NC
(704) 302-8300

THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY

447 MCALISTER RD, LINCOLNTON, NC
(980) 212-5100

THE CHARLOTTE-MECKLENBURG HOSPITAL AUTHORITY

1550 FAULK ST, MONROE, NC
(980) 442-0430

Quick Facts

NPI
1962417451
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
4
Locations
4
Publications
20

Are you this provider?

Claim Your Profile